SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-038326
Filing Date
2023-08-04
Accepted
2023-08-04 07:42:07
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K achl-20230630.htm   iXBRL 6-K 136637
2 EX-99.1 achl-ex99_1.htm EX-99.1 311179
3 EX-99.2 achl-ex99_2.htm   iXBRL EX-99.2 1593622
4 EX-99.3 achl-ex99_3.htm EX-99.3 447615
5 GRAPHIC img60901631_0.jpg GRAPHIC 109156
  Complete submission text file 0000950170-23-038326.txt   8148054

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT achl-20230630_lab.xml EX-101.LAB 384609
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT achl-20230630_cal.xml EX-101.CAL 43186
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT achl-20230630_def.xml EX-101.DEF 139838
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT achl-20230630_pre.xml EX-101.PRE 274482
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT achl-20230630.xsd EX-101.SCH 49262
63 EXTRACTED XBRL INSTANCE DOCUMENT achl-20230630_htm.xml XML 1489568
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40299 | Film No.: 231142191
SIC: 2836 Biological Products, (No Diagnostic Substances)